ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 612223 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 612223; 2) Community: the network communities that were significantly associated with the response to NSC 612223; 3) Molecule: the relationships between components within communities and NSC 612223; 4) MDR: the compounds that were significantly associated with the NSC 612223.

NSC Compound Enrichment Correlation
NSC 701022 Null 0.0392716453377535 0.21320708
NSC 706992 Null 0.0392716453377535 0.11050878
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.20766303
NSC 720495 Null 0.0392716453377535 0.32661791
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.35539326
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0392716453377535 0.022589642
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0392716453377535 0.23262295
NSC 732205 Null 0.0392716453377535 0.33837519
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0392716453377535 -0.0021087847
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0392716453377535 0.39473246
Total:96  Current:81    [First] [Prev] [Next] [Last]